Eden Biodesign, Ltd., an expert provider of biopharmaceutical process development and cGMP manufacturing services, confirmed its expansion plans for Eden Biodesign, Inc., the group's U.S. subsidiary, with the announcement of a facility in Research Triangle Park.
Eden Biodesign, Inc., will offer a range of cell line/strain development and early process development services. The company provides services in support of all major biopharmaceutical production technologies (mammalian, microbial and viral) and offers a "toolbox" of expression technologies, some via collaboration with partner companies.